iTeos Therapeutics, Inc. — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024)

$35.0M

Net Income/Loss (FY2024)

-$134.4M

Total Assets (FY2024)

$687.0M

Total Equity (FY2024)

$590.3M

Cash Flows from Operating Activities (FY2024)

-$98.2M

Source: iTeos Therapeutics, Inc. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.